Mitocin 20mg is indicated for intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection1.
It can also be used Intravenously as monochemotherapy or in combined cytostatic chemotherapy in
• advanced metastatic gastric carcinoma
• advanced and/or metastatic breast cancer1
Available as 20mg mitomycin vial
View the SmPC
Mitocin 20 mg, powder for solution for injection/infusion or intravesical use.
Medicine Information Request
Please complete the medicine information form about this product by following the link below.
Reference: 1) Mitocin SmPC